Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov118510.25208/vdv1185REVIEWSОБЗОР ЛИТЕРАТУРЫResearch ArticleCurrent approaches to the diagnosis of autoimmune bullous dermatosesАктуальные подходы к диагностике аутоиммунных пузырных дерматозовhttps://orcid.org/0000-0002-7689-83506938-4768DrozhdinaMarianna B.ДрождинаМарианна Борисовна
Russian Federation

assistant professor

доцент

drozhdina@yandex.ruhttps://orcid.org/0000-0003-2306-14232534-4480BobroVarvara A.БоброВарвара Андреевна
Russian Federation

postgraduate student

аспирант

bobro.va@inbox.ruhttps://orcid.org/0000-0002-5484-778XSennikovaYuliana A.СенниковаЮлиана Алексеевна
Russian Federation

student

студент

sennikova.yuliana@inbox.ruKirov State Medical AcademyКировский государственный медицинский университет2403202197116263110202009022021Copyright ©; 2021, Drozhdina M.B., Bobro V.A., Sennikova Y.A.Copyright ©; 2021, Дрождина М.Б., Бобро В.А., Сенникова Ю.А.2021Drozhdina M.B., Bobro V.A., Sennikova Y.A.Дрождина М.Б., Бобро В.А., Сенникова Ю.А.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/1185

A modern review of highly effective methods for the diagnosis of autoimmune bullous dermatoses are presented. The specificity of the production of autoantibodies underlying bullous dermatoses are described. Considering the severity of the disease and a significant deterioration in the quality of life of patients suffering from bullous dermatoses; the systematization of diagnostic criteria will help improve the prognosis and management of patients; and it will also help optimize work on the development of targeted drugs for the treatment of patients with this pathology.

Представлен обзор высокоэффективных методов диагностики аутоиммунных пузырных дерматозов. Описана специфика выработки аутоантител; лежащих в основе патогенеза пузырных дерматозов. Учитывая тяжесть течения заболеваний и значительное ухудшение качества жизни пациентов; страдающих пузырными дерматозами; систематизирование диагностических критериев поможет улучшить прогнозирование и тактику ведения пациентов; а также оптимизировать работу по разработке таргетных препаратов для лечения пациентов с данной патологией.

pemphiguspemphigoiddesmogleindesmocollinpectinBP180BP230collagen type VIIlaminindeamidated gliadintissue transglutaminaseantigenic epitopesBIOCHIPmultivariate ELISAпузырчаткапемфигоиддесмоглеиндесмоколлинплектинBP180BP230тип VII коллагеналамининдеамидированный глиадинтканевая трансглутаминазаантигенные эпитопыBIOCHIPмногопараметрический иммуноферментный анализKasperkiewicz M; Ellebrecht CT; Takahashi H; et al. Pemphigus. Nat Rev Dis Primers. 2017;3:17026. doi: 10.1038/nrdp.2017.27Saschenbrecker S; Karl I; Komorowski L; et al. Serological Diagnosis of Autoimmune Bullous Skin Diseases. Front Immunol. 2019;10:1974. doi: 10.3389/fimmu.2019.01974Di Zenzo G; Amber KT; Sayar BS; et al. Immune response in pemphigus and beyond: progresses and emerging concepts. Semin Immunopathol. 2016;38:57–74. doi: 10.1007/s00281-015-0541-1Amber KT; Valdebran M; Grando SA. Non-desmoglein antibodies in patients with pemphigus vulgaris. Front Immunol. 2018;9:1190.doi: 10.3389/fimmu.2018.01190Ahmed AR; Carrozzo M; Caux F; et al. Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology. Exp Dermatol. 2016;25:839–846. doi: 10.1111/exd.13106Дрождина М.Б.; Кошкин С.В. Современный взгляд на клинику; диагностику и лечение вульгарной пузырчатки. Презентация случаев. Иммунопатология; аллергология; инфектология. 2017;3:68-74. [Drozhdina MB; Koshkin SV. Modern view of the clinic; diagnosis and treatment of vulgar pemphigus. Presentation of cases. J Immunopathol.; allergology; infectology. 2017;3:68-74 (In Russ.)]. doi: 10.14427/jipai.2017.3.68Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc. 2004.9:29–33. doi: 10.1111/j.1087-0024.2004.00832.xKim JH; Kim SC. Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa. Front Immunol. 2019;10:1259. doi: 10.3389/fimmu.2019.01259Ohzono A; Sogame R; Li X; et al. Clinical and immunological findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol. 2015;173:1447–1451. doi: 10.1111/bjd.14162Ishii N; Teye K; Fukuda S; et al. Anti-desmocollin autoantibodies in nonclassical pemphigus. Br J Dermatol. 2015;173:59–68.doi: 10.1111/bjd.13711Дрождина М.Б.; Кошкин С.В. Современный взгляд на клинику; диагностику и лечение доброкачественной семейной пузырчатки Гужеро — Хейли — Хейли. Обзор литературы. Вестник дерматологии и венерологии. 2018;94(4):7–14. [Drozhdina MB; Koshkin SV. View of the clinic; diagnosis and treatment of familial benign pemphigus (Hailey-Hailey disease). Literature review. Vestnik Dermatologii i Venerologii. 2018;94(4):7–14 (In Russ.)]. doi: 10.25208/0042-4609-2018-94-4-7-14Дрождина М.Б.; Кошкин С.В. Субкорнеальный пустулез Снеддона — Уилкинсона: Обзор современной литературы. Вестник дерматологии и венерологии. 2019;95(1):15–20. [Drozhdina MB; Koshkin SV. Sneddon-Wilkinson disease: Review of the modern literature. Vestnik Dermatologii i Venerologii. 2019;95(1):15–20 (In Russ.)].doi: 10.25208/0042-4609-2019-95-1-15-20Дрождина М.Б.; Кошкин С.В. Современные представления об этиопатогенезе; особенностях клиники; диагностики и лечения доброкачественной семейной пузырчатки Гужеро — Хейли — Хейли. Описание редкого клинического случая. Вятский медицинский вестник. 2018;59(3):79–84. [Drozhdina MB; Koshkin SV. View of the etiopathogenesis; clinic features; diagnosis and treatment of familial bening pemphigus (Hailey-Hailey disease). Description of rare clinical case. Medical Newsletter of Vyatka 2018;59(3);79–84 (In Russ.)]. doi: 10.25208/0042-4609-2018-94-4-7-14Probst C; Schlumberger W; Stocker W; et al. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta. 2009;410:13–18.doi: 10.1016/j.cca.2009.08.022Zillikens D; Rose PA; Balding SD; et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol. 1997;109:573–579. doi: 10.1111/1523-1747.ep12337492Skaria M; Jaunin F; Hunziker T; et al. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol. 2000;114:998–1004.doi: 10.1046/j.1523-1747.2000.00893.xCharneux J; Lorin J; Vitry F; et al. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol. 2011;147:286–289. doi: 10.1001/archdermatol.2011.23Blocker IM; Dahnrich C; Probst C; et al. Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol. 2012;166:964–970.doi: 10.1111/j.1365-2133.2012.10820.xDi Zenzo G; Calabresi V; Grosso F; et al. The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies. J Invest Dermatol. 2007;127:864–873. doi: 10.1038/sj.jid.5700594Kamaguchi M; Iwata H. The diagnosis and blistering mechanisms of mucous membrane pemphigoid. Front Immunol. 2019;10:34.doi: 10.3389/fimmu.2019.00034Oyama N; Setterfield JF; Powell AM; et al. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol. 2006;154:90–98. doi: 10.1111/j.1365-2133.2005.06998.xLazarova Z; Salato VK; Lanschuetzer CM; et al. IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane; but not bullous; pemphigoid. J Am Acad Dermatol. 2008;58:951–958. doi: 10.1016/j.jaad.2008.02.035Bekou V; Thoma-Uszynski S; Wendler O; et al. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. J Invest Dermatol. 2005;124:732–40.doi: 10.1111/j.0022-202X.2005.23646.xGoletz S; Probst C; Komorowski L; et al. A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid. Br J Dermatol. 2019;180:149–156. doi: 10.1111/bjd.17202Leverkus M; Bhol K; Hirako Y; et al. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin; bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol. 2001;145:998–1004.doi: 10.1046/j.1365-2133.2001.04543.xLi X; Qian H; Sogame R; Hirako Y; et al. Integrin beta4 is a major target antigen in pure ocular mucous membrane pemphigoid. Eur J Dermatol. 2016;26:247–253. doi: 10.1684/ejd.2016.2772Hubner F; Langan EA; Recke A. Lichen planus pemphigoides: from lichenoid inflammation to autoantibody-mediated blistering. Front Immunol. 2019;10:1389. doi: 10.3389/fimmu.2019.01389Zillikens D; Caux F; Mascaro JM; et al. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol. 1999;113:117–121.doi: 10.1046/j.1523-1747.1999.00618.xKoga H; Prost-Squarcioni C; Iwata H; et al. Epidermolysis bullosa acquisita: the 2019 update. Front Med. 2018;5:362. doi: 10.3389/fmed.2018.00362Ishii N; Hamada T; Dainichi T; et al. Epidermolysis bullosa acquisita: what's new? J Dermatol. 2010;37:220–230.doi: 10.1111/j.1346-8138.2009.00799.xKasperkiewicz M; Dahnrich C; Probst C; et al. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides. J Am Acad Dermatol. 2012;66:583–588. doi: 10.1016/j.jaad.2011.02.025Дрождина М.Б.; Кошкин С.В. Современный взгляд на клинику; диагностику и лечение герпетиформного дерматоза Дюринга. Иммунопатология; аллергология; инфектология. 2018;2:74–80. [Drozhdina MB; Koshkin SV. A modern view of the clinic; diagnosis and treatment of dermatosis herpetiformis Duhring. Immunopathology; allergology; infectology. 2018;2:74-–80 (in Russ.)]. doi: 10.14427/jipai.2018.2.78Kamaguchi M; Iwata H; Ujiie I; et al. Direct immunofluorescence using non-lesional buccal mucosa in mucous membrane pemphigoid. Front Med. 2018;5:20. doi: 10.3389/fmed.2018.00020Witte M; Zillikens D; Schmidt E. Diagnosis of autoimmune blistering diseases. Front Med. 2018;5:296. doi: 10.3389/fmed.2018.00296Schmidt E; Zillikens D. The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int. 2011;108:399–III.doi: 10.3238/arztebl.2011.0399Giurdanella F; Nijenhuis AM; Diercks GFH; et al. Keratinocyte binding assay identifies anti-desmosomal pemphigus antibodies where other tests are negative. Front Immunol. 2018; 9:839. doi: 10.3389/fimmu.2018.00839van Beek N; Rentzsch K; Probst C; et al. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis. 2012;7:49.doi: 10.1186/1750-1172-7-49Harman KE; Brown D; Exton LS; et al. British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017. Br J Dermatol. 2017;177:1170–1201. doi: 10.1111/bjd.15930Behzad M; Mobs C; Kneisel A; et al. Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris. Br J Dermatol. 2012;166:844–852. doi: 10.1111/j.1365-2133.2011.10732.xKridin K; Bergman R. The usefulness of indirect immunofluorescence in pemphigus and the natural history of patients with initial false-positive results: a retrospective cohort study. Front Med. 2018;5:266. doi: 10.3389/fmed.2018.00266Ghohestani RF; Nicolas JF; Rousselle P; Claudy AL. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol. 1997;133:1102–1107. doi: 10.1001/archderm.133.9.1102Chan YC; Sun YJ; Ng PP; Tan SH. Comparison of immunofluorescence microscopy; immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid. Clin Exp Dermatol. 2003;28:651–656. doi: 10.1046/j.1365-2230.2003.01419.xLau I; Goletz S; Holtsche MM; et al. Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin. J Am Acad Dermatol. 2019;81(5):1195-1197.doi: 10.1016/j.jaad.2019.03.077Eskin-Schwartz M; Drozhdina M; Sarig O; et al. Epidermolytic ichthyosis sine epidermolysis. Am J Dermatopathol. 2017;39(6):440-444. doi: 10.1097/DAD.0000000000000674Eskin-Schwartz M.; Drozhdina M.; Sarig O. Epidermolytic ichthyosis sine epidermolysis. J Invest Dermatol. 2016;136(5):S67.doi: 10.1016/j.jid.2016.02.414Дрождина М.Б. Паранеопластическая пузырчатка. Современный систематический обзор литературы. Дерматовенерология. Косметология. 2019;5(4):412-422. [Drozhdina MB. Paraneoplastic pemphigus. Modern review of the literature. Dermatovenereology. Cosmetology. 2019;5(4):412-422 (In Russ.)]Vainio E; Kalimo K; Reunala T; et al. Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay. Arch Dermatol Res. 1983;275:15–18. doi:10.1007/BF00516548Wandinger KP; Probst C; Komorowski L; et al. Novel recombinant antigenic targets for the determination of (auto)antibodies in autoimmune dermatoses; neurological disorders and gastrointestinal diseases. In: Conrad K; Chan EKL; Fritzler MJ; Humbel RL; von Landenberg P; Shoenfeld Y; editors. From pathogenesis to therapy of autoimmune diseases. Lengerich: Pabst Science Publishers; 2009. P. 179–190.Дрождина М.Б.; Кошкин С.В. Буллезный пемфигоид. Клиника; диагностика и лечение. Вестник дерматологии и венерологии. 2017(6):47–52. [Drozhdina MB; Koshkin SV. Bullous pemphigoid. Сlinic; Diagnosis and Treatment. Vestnik Dermatologii i Venerologii. 2017(6):47–52 (In Russ.)]. doi: 10.25208/0042-4609-2017-93-6-47-52Özkesici B; Mutlu D; Donmez L; Uzun S. The value of the BIOCHIP mosaic-based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid in Turkish patients. Acta Dermatovenerol Croat. 2017;25:202–209.Sadik CD; Pas HH; Bohlmann MK; Mousavi S; et al. Value of BIOCHIP technology in the serological diagnosis of pemphigoid gestationis. Acta Derm Venereol. 2017;97:128-130. doi: 10.2340/00015555-2460Komorowski L; Muller R; Vorobyev A; et al. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol. 2013; 68:e89–95. doi: 10.1016/j.jaad.2011.12.032Mindorf S; Dettmann IM; Kruger S; et al. Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus. Exp Dermatol. 2017;26:1267–1270. doi: 10.1111/exd.13409Nina van Beek; Stine Krüger; Tarek Fuhrmann; et al. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology. Am J Dermatopathol. 2020;83(5):1315–1322. doi: 10.1016/j.jaad.2020.01.049Дрождина М.Б.; Кошкин С.В.; Иутинская А.О. Современные представления об этиологии; патогенезе; клинике; диагностике и лечении буллезного пемфигоида Левера. Клиническая дерматология и венерология. 2018;17(5)53–58. [Drozhdina MB; Koshkin SV; Iutinskaya AO. Modern concept of the etiology; pathogenesis; clinical presentation; diagnosis; and treatment of Lever-type bullous pemphigoid. Russian journal of clinical dermatology and venereology. 2018;17(5):53–58 (In Russ.)].doi: 10.17116/klinderma 20181705153Кубанов А.А.; Абрамова Т.В.; Знаменская Л.Ф.; Смольянникова В.А. Дифференциальная диагностика буллезных дерматозов: Учебное пособие. М.: ГБОУ ДПО РМАПО; 2015. 56 с. [Kubanov AA; Abramova TV; Znamenskaja LF; Smol'jannikova VA. Differential diagnosis of bullous dermatoses: Training manual. Moscow: GBOU DPO RMAPO; 2015. P. 56 (In Russ.)]. doi: 10.25208/0042-4609-2016-92-6-43-56Абрамова Т.В. Пузырчатка: иммунопатогенез; диагностика и патогенетическая терапия (клинико-экспериментальное исследование): Автор. дисс. док. мед. наук: 14.01.10. ФГБУ ГНЦДК МЗ РФ. Москва; 2019; 48 с. [Abramova TV. Pemphigus: immunopathogenesis; diagnosis and pathogenic therapy (clinical-experimental trial): abstract of the dissertation of the Doctor of Medical Sciences: 14.01.10. FGBU GNCDK MZ RF. Moscow; 2019; P. 48 (In Russ.)]Дрождина М.Б. Клинико-морфологические и молекулярные особенности буллезного эпидермолиза; подходы к классификации. Педиатрия. Журнал им. Г.Н. Сперанского. 2019;98(3):242–252. [Drozhdina MB. Clinico-morphological and molecular peculiarities of epidermolysis bullosa; classification approaches. Pediatria. 2019;98(3):242–252 (In Russ.)]. doi: 10.24110/0031-403X-2019-98-3-242-252Дрождина М.Б.; Кошкин С.В.; Захур И.И.; Бобро В.А. Клиника; диагностика и лечение буллезного эпидермолиза. Иммунопатология; Аллергология; Инфектология. 2019(4):18-26. [Drozhdina MB; Koshkin SV; Zakhur II; Bobro VA. Clinic; diagnostics and treatment of bullous epidermolysis. Immunopathology; Allergology; Infectology. 2019(4):18–26 (In Russ.)]. doi: 10.14427/jipai.2019.4.18Horvath ON; Varga R; Kaneda M; et al. Diagnostic performance of the “MESACUP anti-Skin profile TEST”. Eur J Dermatol. 2016;26:56–63. doi: 10.1684/ejd.2015.2692Махнева Н.В.; Давиденко Е.Б.; Белецкая Л.В. О проблеме диагностики и дифференциальной диагностики аутоиммунной пузырчатки. Альманах клинической медицины. 2014(34):9–14. [Makhneva NV; Davidenko EB; Beletskaya LV. Diagnosis and differential diagnosis of autoimmune pemphigus. Almanakh of clinical medicine. 2014;34:9–14 (In Russ.)]. doi: 10.18786/2072-0505-2014-34-9-14